Skip to main content
. 2010 Apr 19;116(1):71–80. doi: 10.1182/blood-2010-01-261628

Table 2.

Summary of AML cell-line analysis and MDM2 inhibitor treatment IC50 values

AML cell line FAB type p53 (exon 5-9) status Immunoblot (MI-219 10μM 8 hours/16 hours) IC50/MI-219, μM IC50/MI-63, μM IC50/Nutlin, μM
SKM-1 sM5 mut Noninducible > 20 > 10 > 10
OCI-M2 sM6 mut Noninducible > 20 > 10 > 10
MONO-MAC-6 sM5 mut Noninducible > 20 > 10 > 10
GF-D8 M1 mut Noninducible > 20 > 10 > 10
MOLM-16 M0 mut Noninducible > 20 > 10 > 10
Kasumi-3 M0 mut Noninducible > 20 > 10 > 10
Kasumi-1 M2 mut Noninducible > 20 > 10 > 10
ME-1 M4eo mut Null > 20 > 10 > 10
AML-193 M5 mut Null > 20 > 10 > 10
KG-1 M6 mut Null > 20 > 10 > 10
HL60 M2 deleted Null > 20 > 10 > 10
OCI-AML-3 M4 wt Inducible 18.176 > 10 > 10
OCI-AML-5 M4 wt Inducible 13.846 > 10 > 10
ML-2 sM4 wt Inducible 7.038 7.468 10.447
OCI-AML-2 M4 wt Inducible 5.248 4.735 7.216
AP-1060 M3 wt Inducible 4.224 4.029 6.768
SIG-M5 M5a wt Inducible 3.436 3.801 4.727
MOLM-13 sM5a wt Inducible 2.657 2.855 4.044
MUTZ-2 M2 wt Inducible 1.283 1.17 0.951

mut indicates mutated; and wt, wild-type.